5 Best Stocks To Buy Now For June 2025
Market volatility and recent trade developments have created distinct opportunities across multiple sectors, from artificial intelligence powerhouses to healthcare giants navigating regulatory changes. Savvy investors are recognizing that current market dislocations often mask underlying business strength, particularly among companies with proven track records of innovation, market leadership and adaptability to changing economic conditions.
This analysis identifies five compelling investment opportunities spanning technology, healthcare, industrials and data analytics sectors. Each selection represents companies well-positioned to benefit from long-term secular trends, trading at levels that offer attractive risk-adjusted returns for investors with suitable time horizons and risk tolerance.
The selection process emphasized companies demonstrating strong competitive moats, consistent revenue growth and clear catalysts for future expansion. Priority was given to market leaders within their respective industries, particularly those benefiting from transformative trends such as the adoption of artificial intelligence, healthcare innovation, industrial automation, and data-driven decision-making across enterprise markets.
Each company needed to show resilient business models capable of generating sustainable cash flows while investing in growth initiatives. Special consideration was given to management teams with proven execution capabilities, strong balance sheets that provide strategic flexibility and business models positioned to benefit from ongoing technological and demographic shifts reshaping the global economy.
Honeywell International stands as a premier diversified technology and manufacturing company, operating across aerospace, building technologies, performance materials and safety solutions. The company has successfully transformed itself into a software-enabled industrial leader, developing connected solutions that address critical challenges in automation, energy efficiency and digital transformation. Recent strategic initiatives focus on sustainable technologies, including renewable fuels, carbon capture solutions and next-generation automation systems.
The company's diversified portfolio provides natural hedging against industry-specific downturns while positioning it to benefit from multiple long-term growth drivers. Honeywell's aerospace division serves both commercial and defense markets. At the same time, its building technologies segment capitalizes on increasing demand for innovative building solutions and energy management systems that reduce operational costs and environmental impact.
Honeywell represents exceptional value in the industrial technology space, combining steady dividend income with significant growth potential from emerging technologies. The company's transformation toward higher-margin software and services has improved profitability metrics while reducing cyclical exposure. Operating margins have expanded to over 20%, with return on invested capital consistently above 15%, reflecting disciplined capital allocation and strong pricing power.
Recent aerospace recovery trends benefit multiple business segments as commercial aviation continues normalizing and defense spending remains robust globally. Honeywell's Aerospace division contributed nearly 40% of total revenue in the last fiscal year and is expected to grow further as backlogs normalize and global air travel rebounds.
The Building Technologies division positions Honeywell perfectly for the ongoing shift toward smart infrastructure and energy-efficient solutions, particularly as regulatory requirements drive the adoption of automated building management systems. This segment also supports a recurring revenue model through service contracts and software subscriptions, contributing to earnings stability.
Management's consistent operational execution, combined with strategic investments in breakthrough technologies like sustainable aviation fuel and quantum computing applications, creates multiple pathways for long-term value creation while maintaining attractive current income through reliable dividend payments. With a payout ratio under 50% and consistent dividend increases, Honeywell remains a compelling choice for income-focused investors seeking exposure to industrial innovation.
NVIDIA Corporation has emerged as the undisputed leader in artificial intelligence computing, providing the essential hardware and software infrastructure powering the global AI revolution. The company's graphics processing units form the foundation for machine learning, data center acceleration, autonomous vehicle development and scientific computing applications across virtually every industry. Recent strategic partnerships, including collaborations with major technology companies and governments, demonstrate the critical nature of NVIDIA's technology in next-generation computing applications.
The company's comprehensive AI platform extends beyond hardware to encompass software frameworks, development tools and cloud services, fostering long-term customer relationships and generating recurring revenue streams. NVIDIA's data center business has become the primary driver of growth. At the same time, gaming, professional visualization, and automotive segments provide diversification and additional expansion opportunities as AI capabilities are integrated across more applications.
NVIDIA occupies a virtually unassailable position in one of the most transformative technology trends of this generation, with artificial intelligence adoption still in its early stages across most industries. Recent partnerships, including collaborations with Saudi Arabia on AI initiatives, demonstrate the global strategic importance of NVIDIA's technology and provide new revenue opportunities in emerging markets seeking to build AI capabilities.
The company's technological moat continues widening as competitors struggle to match NVIDIA's integrated hardware-software approach and extensive developer ecosystem. Gross margins remain strong, above 70%, reflecting the company's ability to command premium pricing in a high-demand market. While the stock trades at premium valuations, the massive addressable market for AI computing, combined with NVIDIA's dominant market share and accelerating adoption rates across enterprise and government sectors, justifies higher multiples. The company's ability to maintain pricing power while scaling production positions it for sustained revenue and margin expansion as AI infrastructure investments accelerate globally.
UnitedHealth Group operates as America's largest healthcare company, serving over 50 million members through its UnitedHealthcare insurance business while providing comprehensive health services through its rapidly growing Optum division. The company has built an integrated healthcare ecosystem that combines insurance, pharmacy benefits, medical care delivery and health technology solutions, improving patient outcomes while reducing overall system costs.
Despite recent stock volatility related to regulatory concerns, UnitedHealth's fundamental business model remains strong, benefiting from aging demographics, increasing healthcare utilization and the ongoing shift toward value-based care arrangements. The Optum division has become a significant growth driver, providing technology-enabled services that help healthcare providers improve efficiency and patient care quality.
UnitedHealth's current valuation appears compelling given its dominant market position and multiple growth drivers across both insurance and services businesses. The recent regulatory-driven volatility, exacerbated by a high-profile fraud lawsuit, has led to a steep selloff, pushing the stock down significantly and compressing its valuation to a forward P/E of just 12. For a company with UnitedHealth's scale, diversified revenue streams and consistent double-digit earnings growth over the past decade, this represents a rare opportunity to buy a high-quality business at a deep discount.
The company's integrated model provides competitive advantages that are difficult to replicate. Healthcare spending continues growing faster than GDP, driven by demographic trends and medical innovation, creating a favorable operating environment. The company's investment in technology and data analytics capabilities positions it well for the ongoing transformation toward personalized medicine and value-based care delivery models. Optum's expansion into new markets and services provides significant revenue diversification beyond traditional insurance operations, while the company's strong balance sheet enables continued strategic acquisitions and organic growth investments. The combination of defensive healthcare exposure and growth potential makes UnitedHealth attractive despite near-term legal and regulatory headwinds.
Johnson & Johnson stands as one of the world's most diversified healthcare companies, combining leading pharmaceutical research with innovative medical devices and trusted consumer health products. The company's pharmaceutical division develops breakthrough treatments for cancer, immunology, infectious diseases, and neurological conditions, while its medical device business serves the global surgical, orthopedic, and vision care markets.
The company has demonstrated remarkable consistency over decades, generating steady cash flows that support continuous research investment and regular dividend increases spanning over 60 years. Recent strategic initiatives include expanding oncology and immunology portfolios through both internal development and strategic acquisitions, while divesting non-core consumer brands to focus on higher-growth healthcare segments with stronger competitive positioning.
Johnson & Johnson offers exceptional stability combined with growth potential from its industry-leading pharmaceutical pipeline and medical device innovations. The company's diversified revenue streams provide resilience during economic uncertainty. At the same time, its strong research capabilities and established regulatory relationships enable the successful development of breakthrough treatments that command premium pricing and market share.
The pharmaceutical division's focus on high-value therapeutic areas, such as oncology and immunology, aligns with some of healthcare's fastest-growing segments—meanwhile, the medical device business benefits from aging demographics and increasing demand for minimally invasive surgical procedures. Management's disciplined capital allocation, combined with the company's AAA credit rating and commitment to dividend growth, makes Johnson & Johnson particularly attractive for conservative investors seeking reliable income growth, capital preservation and upside potential from medical innovation.
Palantir Technologies specializes in big data analytics platforms that enable organizations to integrate, analyze and act upon massive datasets for critical decision-making. The company serves both government and commercial clients through its Gotham platform for defense and intelligence applications and Foundry platform for enterprise customers across industries, including healthcare, energy, manufacturing and financial services.
The company's software enables customers to uncover hidden patterns in complex data, optimize operations and make data-driven decisions that were previously impossible due to technological limitations. Recent commercial expansion has accelerated as enterprises recognize the competitive advantages provided by advanced analytics capabilities. At the same time, government contracts continue providing a stable revenue foundation and development funding for cutting-edge capabilities.
Palantir operates at the intersection of several powerful trends, including the adoption of artificial intelligence, digital transformation and data-driven decision-making across both government and enterprise markets. The stock's strong 2025 performance reflects growing recognition of the company's unique capabilities and expanding market opportunities as organizations prioritize analytics investments to maintain competitive advantages.
The company's government relationships provide both revenue stability and access to cutting-edge use cases that drive product development, while commercial market expansion offers significant scalability potential. Palantir's software platforms create high switching costs once implemented, leading to strong customer retention and expanding usage over time. The increasing importance of data analytics across all industries, combined with Palantir's proven ability to handle complex, mission-critical applications, positions the company for sustained growth as digital transformation accelerates across both public and private sectors.
Bottom Line
These five stocks represent diverse opportunities across technology, healthcare, and industrial sectors, each positioned to benefit from powerful long-term trends. From NVIDIA's AI dominance to Johnson & Johnson's healthcare stability, UnitedHealth's integrated model and ultra cheap valuation due to regulatory risks, Honeywell's industrial innovation, and Palantir's data analytics leadership, investors gain exposure to multiple growth drivers while balancing risk across different market segments and business models.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
36 minutes ago
- Medscape
ADA Issues New MASLD Guidelines
A new consensus report from the American Diabetes Association (ADA) provides a practice-oriented framework for screening and managing metabolic dysfunction–associated steatotic liver disease (MASLD) in people with diabetes and prediabetes. Published online on May 28, 2025, in Diabetes Care, the report is a comprehensive update to the recommendations the ADA released in 2023. It is intended for clinicians treating patients with diabetes — primarily type 2 diabetes (T2D) — but also type 1 diabetes with obesity and prediabetes. Topics covered include the rationale for the recent change in terminology, epidemiology, fibrosis risk stratification, monitoring, treatment, and referral guidance, with interprofessional team management emphasized throughout. 'This will provide primary care doctors and anyone taking care of people with diabetes the tools to diagnose [MASLD] early and guide therapy…to prevent cirrhosis, and refer to the hepatologist as needed for additional therapy and monitoring,' lead author Kenneth Cusi, MD, professor of medicine at the Division of Endocrinology, Diabetes & Metabolism in the Department of Medicine at the University of Florida, Gainesville, Florida, told Medscape Medical News . The guidelines recommend that clinicians routinely screen people with T2D or prediabetes for MASLD. 'We explain that the liver should be incorporated into our management in the same way we do for chronic kidney disease, eye disease, and nerve disease as an end-organ damage that is particularly affected by diabetes,' Cusi said. In the United States, at least 70% of people with T2D have MASLD, about half of whom have the more progressive form termed metabolic dysfunction–associated steatohepatitis (MASH). About 1 in 5 with T2D have advanced liver fibrosis. The presence of MASH increases the risks for complications including cirrhosis, hepatocellular carcinoma, and overall mortality, according to the new consensus report. Liver disease has not been a focus of diabetes management until recently, Cusi noted. 'We didn't think about it. The epidemic of obesity, and with that, of diabetes, is driving this liver disease. The obesity epidemic has had a big worsening since the 1990s, so this damage in the past 20 or 30 years is just now becoming evident in the liver.' Terminology Change: Highlighting Insulin Resistance, Reducing Stigma The document reviews the current nomenclature for SLD, which was officially changed in 2023 to remove the words 'fatty' and 'alcoholic.' Now, MASLD is defined as the presence of SLD with at least one metabolic risk factor such as obesity, hypertension, prediabetes, high triglycerides, low high-density lipoprotein cholesterol, or T2D, with minimal or no alcohol consumption (< 20 g/d for women; < 30 g/d for men). The term 'MetALD' is used for those with MASLD who also have increased alcohol consumption (20-50 g/d for women; 30-60 g/day for men). Steatosis in the setting of alcohol consumption above those levels is termed 'alcohol-associated liver disease (ALD).' The term MASH is defined as steatohepatitis with at least one metabolic risk factor and minimal alcohol consumption. 'At-risk MASH' refers to steatohepatitis with clinically significant fibrosis (stage F2 or higher). Diagnosis: Staged Screening for Fibrosis The document recommends routine screening of people with T2D, prediabetes, and/or obesity with cardiovascular risk factors, with the goal of identifying those with high-risk MASH. Intervention is then aimed at preventing fibrosis progression and cirrhosis. A graphic diagnostic algorithm advises initial use of the noninvasive Fibrosis-4 (FIB-4) tool, which risk stratifies based on age, liver enzymes, and platelet count. 'The FIB-4 is composed of very simple things that are already in the electronic medical record of all patients. We also discuss the role of electronic medical records to improve implementation,' Cusi said. Those with a FIB-4 < 1.3 have a low risk for future cirrhosis and can be managed in primary or team care with optimized lifestyle and repeated FIB-4 every 1-2 years. If the FIB-4 is > 2.67, direct referral to a liver specialist is advised. If FIB-4 is between 1.3 and 2.67, a second risk-stratification test is recommended. Ideally, this would be a liver stiffness measurement (LSM), most commonly with transient elastography. If that is unavailable, an alternative is the noninvasive enhanced liver fibrosis (ELF) test. If the LSM is < 8.0 kPa or ELF is < 7.7, the fibrosis risk is low and routine management can continue with repeat testing in 1-2 years. But if higher, hepatology referral is recommended. Treatment: Lifestyle, Plus Old and New Drugs The report details lifestyle modification for MASLD, including nutrition plans; physical activity; behavioral health; and the role of diabetes self-management, education and support. The role of obesity treatment in people with MASLD, both metabolic surgery and pharmacotherapy, is also discussed at length. No current pharmacologic treatments have been approved for MASLD, but both semaglutide and tirzepatide have demonstrated benefit in treating MASH and are approved for treating T2D, obesity, and other related comorbidities. A thyroid hormone receptor beta agonist, resmetirom, was approved in early 2024 for the treatment of MASH with fibrosis stages F2 and F3, but is extremely expensive at about $50,000 a year, Cusi noted. An older, generic glucose-lowering drug, pioglitazone, has also shown benefit in reducing fibrosis and may be a lower-cost alternative. The document also includes a section on alcohol intake, which complicates the MASLD picture, Cusi noted. 'We think that this is going to help doctors to consider alcohol, which is often overlooked and under-reported. If patients have moderate fibrosis, they should completely quit alcohol.' Cusi has received research support (to his institution) from Boehringer Ingelheim, Echosens, Inventiva, Labcorp, and Perspectum, and has served as a consultant for Aligos Therapeutics, Arrowhead, AstraZeneca, 89bio, Bristol-Myers Squibb, Boehringer Ingelheim, Eli Lilly, GlaxoSmithKline, Novo Nordisk, ProSciento, Sagimet Biosciences, Siemens USA, Zealand Pharma, and Terns Pharmaceuticals.
Yahoo
36 minutes ago
- Yahoo
Palm Beach Police: 'SIM swap' scam tried to steal more than $200,000 from Palm Beacher
Two Westlake residents have been arrested by Palm Beach Police, who say the pair executed an elaborate financial fraud known as "SIM swapping" that attempted to steal more than $200,000 from a Palm Beach resident. And the scheme could extend far beyond the island, police said. The pair were taken into custody May 28, Palm Beach Police spokesman Capt. Will Rothrock said. A 29-year-old woman faces charges of organized fraud and fraudulent use of personal information of a person age 60 or older, and a 31-year-old man was arrested on a charge of fraudulent use of personal information, according to arrest reports. Both remained at the Palm Beach County Jail on May 29. The woman was held without bond, and a Palm Beach County judge ordered that she have no contact with the Palm Beach resident or the man arrested in the case, according to court records. She also cannot have any devices that can access the internet, and she is not allowed to use the phone except to contact her attorney, court records show. The man's bond amount was set at $350,000, and he also cannot use or have any devices that connect to the internet, court records show. He was directed not to contact the Palm Beach resident or the woman, and while in jail, he cannot use the phone except to contact an attorney, according to court records. If he makes bond, he will be on in-home arrest with a GPS monitor, records show. On April 10, a Palm Beach resident called police to say someone had fraudulently accessed his AT&T and bank accounts, and had tried to transfer money and login to several websites, according to an arrest report. The Palm Beach resident said he received a call on April 8 from someone who said they were with AT&T, and that he needed to validate his phone numbers using a code sent to him via text message, an arrest report said. About 20 minutes after that phone call, phone numbers connected to the resident's AT&T account stopped working, police said. The scam is known as "SIM swapping" or "SIM hijacking," according to the Federal Bureau of Investigation's Internet Crime Complaint Center, also called the IC3. Fraudsters will gain control of a person's phone number and then use it to access their banking and other financial and personal accounts, the agency said. The resident provided the code that he received to the person, but later discovered that the code was used to forward his phone number to a different provider, Verizon, police said. By giving that code to the person who said they were from AT&T, he allowed them to complete the final step to move all three of the phone numbers on his account to the other carrier, police wrote in the arrest report. In 2024, there were 982 complaints of SIM swapping with a total reported loss of $25,983,946, the IC3 said in its annual report. The previous year, 1,075 SIM swapping complaints were made with a reported loss of $48,798,103, according to the IC3. Once the phone numbers were transferred, someone tried to withdraw money and make a wire transfer from the Palm Beach resident's bank account, police said. Someone also successfully took over one of the man's email accounts. Transactions made through the resident's accounts included $2,300 sent via Zelle to a St. Petersburg resident, $77.97 spent at a Circle K in The Acreage, $1,500 in ATM withdrawals, and a $215 Venmo payment, an arrest report said. There was also a $4,006.08 payment made to designer clothing retailer Farfetch U.K., along with Airbnb charges of $2,341.79 and $660, an arrest report said. Because the resident was concerned that his Apple account had been compromised, he used the "Find My" feature on his iPhone, which can be used to locate devices connected to an Apple account, police said. The resident saw an unknown iPhone on Liberty Lane in Westlake and told police that he has never been to that address and has no connections there. A Palm Beach Police detective later drove by that address several times and saw two vehicles, a 2022 black Cadillac Escalade and 2024 gray BMW SUV, parked there. Both vehicles were registered to the 31-year-old man, whose driver's license lists an address in North Lauderdale but who police learned was staying at the house in Westlake with the 29-year-old woman, who shares registration on the BMW SUV. Palm Beach Police detectives discovered that the ATM withdrawals from the resident's account were made at a bank in The Acreage, about 2 miles from the house in Westlake, an arrest report said. On April 9, the Palm Beach resident received a request to wire transfer $138,237, which was unsuccessful, police said. That same day, there was another request for a wire transfer for $82,469. The banker in that case confirmed the wire with who he believed to be the account holder, and the transfer was initiated, police said. However, once the resident received an email to confirm the transfer, he called the bank's fraud team and was able to secure the money, but it could take up to three months to get that money back, the arrest report said. Both wire transfer requests were made to a Pompano Beach resident, police said. The resident hired a private investigator who recovered photos taken by the Liberty Lane-located iPhone after someone took over the resident's Apple account, police said. Data for seven photos show all were taken at that home in Westlake, according to the arrest report. On May 7, a Palm Beach Police detective talked with a person in Las Vegas, Nevada, who had been the victim of a similar scheme and had reported the crime to the FBI. That person gave police about 50 images someone took after gaining control of his Apple account, and officers found data that connected the photos back to the Westlake address. The images provided by the person in Nevada also included photos of driver's licenses, passports, bank account numbers, emails and more, an arrest report said. When Palm Beach Police and the Palm Beach County Sheriff's Office searched the Westlake home on a warrant on May 5, they found the 29-year-old woman and 31-year-old man, along with a Louis Vuitton backpack, three iPhones, two pairs of sunglasses and a yellow notebook with "Work $" written on it, the arrest report said. Inside the notebook, officers said they found bank account details, Social Security numbers, addresses, names and more personal details about more than 50 people in Florida and across the United States. Officers also said they found electronic devices and a ledger that contained the Palm Beach resident's personal information. They also took $15,243 in cash from the woman's bedroom, the arrest report said. Detectives determined that once the couple gained access to a person's phone line, they could "circumvent two-factor authentication and gain access to victims' financial accounts, resulting in substantial unauthorized wire transfers and fraudulent transactions," the arrest report said. Palm Beach has cautioned residents to be wary of potential scams. "Most of these cases nationally go unsolved," Rothrock said. "The work and tenacity that our detectives put into this to follow the leads to the end and bring a successful conclusion are noteworthy." He added that the department is grateful for PBSO's help in the investigation, including to serve the search warrant. "Finding local perpetrators was a rarity and did make the investigation coordination smoother," Rothrock said. Those who believe they may have been victims of the scam should call the Palm Beach Police Department's non-emergency number at 561-838-5454, he said. This story was updated to add new information. Kristina Webb is a reporter for Palm Beach Daily News, part of the USA TODAY Florida Network. You can reach her at kwebb@ Subscribe today to support our journalism. This article originally appeared on Palm Beach Post: Palm Beach 'SIM swap' scam could extend across U.S., police say
New York Times
36 minutes ago
- New York Times
Man City pursuing deal to sign Rayan Ait Nouri from Wolves
Manchester City are pursuing a deal to sign Rayan Ait Nouri from Wolverhampton Wanderers. Agreements still need to be reached between the clubs and with the 23-year-old — however all parties now expect a move to happen. Ait Nouri has emerged as City's top target to strengthen at left-back after four impressive seasons since joining Wolves on a permanent basis, which followed a loan spell, from Angers. Advertisement Pep Guardiola's side are working to secure the Algeria international and further recruits before the Club World Cup in the United States this summer. Premier League clubs voted to approve allowing the window to open on June 1 before closing on June 10, with the tournament kicking off four days later. City face Wydad AC, Al Ain and Juventus in Group G of the newly-expanded competition. Ait Nouri has made 157 appearances for Wolves since joining the Midlands club, initially on loan, in 2020. He made 41 appearances in all competitions this season, scoring five goals and adding seven assists. Central defender Josko Gvardiol was City's most regular left-back before academy graduate midfielder Nico O'Reilly starred in the position over the final months of the campaign. ()
